Pure Bioscience (OTC: PURE) is focused on developing and commercializing its proprietary antimicrobial products primarily in the food safety arena — providing solutions to the health and environmental challenges of pathogen and hygienic control. The company’s technology platform is based on patented stabilized ionic silver; its initial products contain silver dihydrogen citrate, or SDC, a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection and formulates well with other compounds. As a platform technology, SDC is distinguished from existing products in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it.  For more information, visit the company’s website at www.purebio.com